Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Inclusion Criteria: * Age ≥ 3 months to 12 years old * Clinical diagnosis of atopic dermatitis * History of mild to moderate atopic dermatitis * Investigator Global Assessment ≥ 1 (almost clear/clear of disease) * Written informed consent Exclusion Criteria: * Investigator Global Assessment ≥ 4 (severe/very severe disease) * Patients with active skin viral infections (i.e, herpes simplex, herpes zoster, varicella) * Patients with atopic dermatitis, with active clinical infection on area of disease. All active infections must be treated prior to trial inclusion * Patients in an Immunosuppressive state or with history of malignant disease * Patients with clinical conditions other that Atopic Dermatitis that according to the investigator may interfere with the evaluation (i.e, Psoriasis, Netherton Syndrome) * Other protocol-defined inclusion/exclusion criteria may apply